WO2006030402A3 - Dispositif d'administration osmotique a deux compartiments - Google Patents

Dispositif d'administration osmotique a deux compartiments Download PDF

Info

Publication number
WO2006030402A3
WO2006030402A3 PCT/IB2005/053076 IB2005053076W WO2006030402A3 WO 2006030402 A3 WO2006030402 A3 WO 2006030402A3 IB 2005053076 W IB2005053076 W IB 2005053076W WO 2006030402 A3 WO2006030402 A3 WO 2006030402A3
Authority
WO
WIPO (PCT)
Prior art keywords
delivery device
osmotic delivery
dual compartment
semipermeable membrane
compartment osmotic
Prior art date
Application number
PCT/IB2005/053076
Other languages
English (en)
Other versions
WO2006030402A2 (fr
Inventor
Rajan Kumar Verma
Narayanan Badri Viswanathan
Rajeev Singh Raghuvanshi
Ashok Kumar Rampal
Original Assignee
Ranbaxy Lab Ltd
Rajan Kumar Verma
Narayanan Badri Viswanathan
Rajeev Singh Raghuvanshi
Ashok Kumar Rampal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Rajan Kumar Verma, Narayanan Badri Viswanathan, Rajeev Singh Raghuvanshi, Ashok Kumar Rampal filed Critical Ranbaxy Lab Ltd
Publication of WO2006030402A2 publication Critical patent/WO2006030402A2/fr
Publication of WO2006030402A3 publication Critical patent/WO2006030402A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un dispositif d'administration osmotique à deux compartiments et des procédés d'élaboration correspondants.
PCT/IB2005/053076 2004-09-17 2005-09-19 Dispositif d'administration osmotique a deux compartiments WO2006030402A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1763DE2004 2004-09-17
IN1763/DEL/2004 2004-09-17

Publications (2)

Publication Number Publication Date
WO2006030402A2 WO2006030402A2 (fr) 2006-03-23
WO2006030402A3 true WO2006030402A3 (fr) 2006-05-18

Family

ID=35708749

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/053076 WO2006030402A2 (fr) 2004-09-17 2005-09-19 Dispositif d'administration osmotique a deux compartiments

Country Status (1)

Country Link
WO (1) WO2006030402A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
WO2003024429A1 (fr) 2001-09-21 2003-03-27 Egalet A/S Systeme de liberation a base de polymere
ATE495732T1 (de) 2003-03-26 2011-02-15 Egalet As Morphin-system mit kontrollierter freisetzung
WO2006046114A2 (fr) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Formes posologiques osmotiques a taux croissant de liberation du medicament, et leurs procedes de preparation
WO2008148798A2 (fr) 2007-06-04 2008-12-11 Egalet A/S Compositions pharmaceutiques à libération contrôlée pour un effet prolongé
CA2751667C (fr) 2009-02-06 2016-12-13 Egalet Ltd. Composition a liberation immediate resistant a une maltraitance par prise d'alcool
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
MX2014015880A (es) 2012-07-06 2015-08-05 Egalet Ltd Composiciones farmaceuticas disuasivas de abuso para liberacion controlada.
CA3042642A1 (fr) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Comprime extrude anti-abus a liberation immediate
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9707184B2 (en) 2014-07-17 2017-07-18 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
CN104224756A (zh) * 2014-09-26 2014-12-24 天津市聚星康华医药科技有限公司 一种甲磺酸多沙唑嗪口腔速溶膜及其制备方法
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
CN106727406B (zh) * 2017-01-04 2018-01-19 北京汇诚瑞祥医药技术有限公司 一种含多沙唑嗪的控释组合物及其制备方法
CN115025058B (zh) * 2021-02-23 2024-01-26 成都同道慧宜生物医药科技有限公司 零级缓释药剂及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0334465A1 (fr) * 1988-03-21 1989-09-27 Alza Corporation Dispositif pour doser un médicament pour la thérapie humaine
WO1990008536A1 (fr) * 1989-01-30 1990-08-09 Alza Corporation Forme de dosage pour administrer un antagoniste du calcium
US5028434A (en) * 1988-07-21 1991-07-02 Alza Corporation Method for administering nilvadipine for treating cardiovascular symptoms
US5713852A (en) * 1995-06-07 1998-02-03 Alza Corporation Oral dosage and method for treating painful conditions of the oral cavity
US20040170680A1 (en) * 2001-05-02 2004-09-02 Benjamin Oshlack Once-a-day oxycodone formulations

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0334465A1 (fr) * 1988-03-21 1989-09-27 Alza Corporation Dispositif pour doser un médicament pour la thérapie humaine
US5028434A (en) * 1988-07-21 1991-07-02 Alza Corporation Method for administering nilvadipine for treating cardiovascular symptoms
WO1990008536A1 (fr) * 1989-01-30 1990-08-09 Alza Corporation Forme de dosage pour administrer un antagoniste du calcium
US5713852A (en) * 1995-06-07 1998-02-03 Alza Corporation Oral dosage and method for treating painful conditions of the oral cavity
US20040170680A1 (en) * 2001-05-02 2004-09-02 Benjamin Oshlack Once-a-day oxycodone formulations

Also Published As

Publication number Publication date
WO2006030402A2 (fr) 2006-03-23

Similar Documents

Publication Publication Date Title
WO2006030402A3 (fr) Dispositif d'administration osmotique a deux compartiments
WO2005099667A3 (fr) Compositions d'administration de medicaments
DE60237372D1 (de) Magenretentionssystem mit kontrollierter arzneimittelfreisetzung
WO2006101882A3 (fr) Formulations galeniques de medicaments, dispositifs et procedes associes
WO2005044224A3 (fr) Systeme d'administration de medicament, faisant appel a des nanocoques polymeres
WO2004103336A3 (fr) Systeme d'administration de medicaments
WO2005018702A3 (fr) Systemes de distribution d'agents actifs comprenant un melange de polymeres miscibles, dispositifs medicaux et procedes
CA2396152A1 (fr) Dispositif osmotique place a l'interieur d'un autre dispositif osmotique
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
WO2000040203A3 (fr) Agents d'administration polymeres et composes d'agents d'administration
ATE515949T1 (de) Süssware
WO2008060963A3 (fr) Formulations pharmaceutiques en couches
TW200719915A (en) Flavoring of drug-containing chewing gums
MX2007002189A (es) Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
WO2005048952A3 (fr) Composition et forme galenique contenant une molecule amphiphile comme excipient de suspension
WO2006017245A3 (fr) Polymeres de styrene sulfones pour articles medicaux et dispositifs de voiles barrieres
WO2005027794A3 (fr) Dispositifs medicaux
WO2005097064A3 (fr) Medicaments au gout masque lors de la rupture des matieres particulaires multiples
WO2007082186A3 (fr) Dispositifs d'administration de médicament bioabsorbable
AU2003258209A1 (en) Active agent delivery systems, medical devices, and methods
WO2002019969A3 (fr) Acide (5-(2-hydroxy-4-chlorobenzoyl) aminovalerique et ses sels, compositions contenant l'acide et ses sels pour acheminer des agents actifs
AU2002231691A1 (en) Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
WO2005055973A3 (fr) Agents endoparasiticides a application topique
DE60211464D1 (de) Pharmazeutische formulierungen mit kontrollierter wirkstoff-freigabe enthaltend milchsäure-polymer, sowie deren herstellung
WO2007122510A3 (fr) Membranes asymétriques pour dispositifs de distribution de médicament

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase